Comparison of methods for preparation of 125I brachytherapy source cores for the treatment of eye cancer

References

Page 1

	Year	Citations
Two‐dimensional dose distribution of <sup>1</sup><sup>2</sup><sup>5</sup>I seeds Charlotte Ling, Michael C. Schell, Ellen Yorke, Medical Physics Source EncapsulationDose DistributionBrachytherapyModel 6711Radiation Dose	1985	75
Comparison of I‐125 sources used for permanent interstitial implants B Heintz, Robert E. Wallace, James M. Hevezi Medical Physics	2001	62
Dosimetric characteristics of the Pharma Seed™ model BT-125-I source C. Popescu, J. Wise, Keith Sowards, Medical Physics Anisotropy ConstantPharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingBrachytherapy	2000	49
A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancer Chithra M. Mathew, M. A. Majali, Sreedevi Balakrishnan Applied Radiation and Isotopes Silver WireNanomedicineChemical EngineeringEngineeringBrachytherapy	2002	46
Dosimetry of the I‐Plant Model 3500 iodine‐125 brachytherapy source Dennis M. Duggan, Brian Johnson Medical Physics	2001	37
The dosimetry of <sup>1</sup><sup>2</sup><sup>5</sup>I seed eye plaques Keith A. Weaver Medical Physics Eye Plaque TherapyDose AnisotropyHealth SciencesRadiation TherapyOphthalmology	1986	33
Model 3500 125I brachytherapy source dosimetric characterization Robert E. Wallace Applied Radiation and Isotopes BrachytherapyDosimetryRadiation Therapy PlanningModel 3500Medicine	2002	22
An iodine-125 plaque for radiotherapy of the eye: manufacture and dosimetric considerations A.N. Harnett, E. S. Thomson British Journal of Radiology	1988	12
Separation of iodine species by adsorption chromatography A. V. B. Bellido Journal of Radioanalytical and Nuclear Chemistry	2001	10

Page 1